home All News open_in_new Full Article

Neurenati Therapeutics Welcomes Dr Daniel Guay to Its Board of Directors and Dr Carlo Di Lorenzo to Its Scientific and Clinical Advisory Board

MONTREAL — Neurenati Therapeutics, a biotech company focused on the development of therapies for rare diseases, is pleased to appoint two highly-experienced members to its Board of Directors and Scientific and Clinical Advisory Board. Dr. Daniel Guay is a seasoned executive with over 30 years of experience in drug development (Merck, Institute for Research in […]


today 8 d. ago attach_file Transport

attach_file Economics
attach_file Politics
attach_file Other
attach_file Sport
attach_file Culture
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Sport
attach_file Events
attach_file Society
attach_file Culture
attach_file Other
attach_file Events
attach_file Sport
attach_file Technology
attach_file Other
attach_file Other
attach_file Other


ID: 3414141237
Add Watch Country

arrow_drop_down